Q1 2023 closes with 3X Year over Year OcNOS® sales jump, led by Data Center, Aggregation Router and Cell Site Router products
SANTA CLARA, Calif., May 30, 2023 – IP Infusion, a leading provider of open network software and solutions for wireline and mobile network operators, announced today that the company is experiencing sustained record-breaking growth, with 1Q 2023 sales the highest ever for a single quarter. This year's first quarter OcNOS® sales orders are more than three times Year over Year compared to Q1 2022, led by robust demand for OcNOS's disaggregated Data Center, Aggregation Router and Cell Site Router products.
In addition, 23 new customers in the first quarter chose OcNOS, the industry's first and preferred full-featured modular extensible network OS designed for white box open networking solutions. New customer announcements include Netplus Broadband, MetaLINK Technologies, Amplex Internet, Broadstar, Multinet、および Pine Networks. IP Infusion also announced in Q1 2023 that it collaborated with NTT Corporation (NTT) for the development of Beluganos, a new network operating system to realize NTT's IOWN concept, and is providing sales and support for its global markets.
"IP Infusion is proud to report yet another unequaled quarter of sales growth fueled by a powerful demand for our industry-acclaimed OcNOS products," said Atsushi Ogata, President and CEO of IP Infusion. "This solid performance reflects our commitment to exceed expectations for delivering the most advanced disaggregated solutions to our expanding customer base and partners across the globe."
IP Infusion について
IP Infusion manufactures open network software and solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion is a market leader in Network Operating Systems. Our flagship software platform OcNOS® allows network operators to disaggregate their networks, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier-grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. Northforge Innovations is a registered trademark of Northforge Innovations, Inc. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.
-end-
メディア窓口
Katherine Verducci
1903 PR
kverducci@1903pr.com
408.429.5779
IP Infusion について
IP Infusion はオープンネットワーキングソフトウェアの主要プロバイダーであり、サービスプロバイダー、データセンター、AI ファブリックネットワーク向けのキャリアグレードネットワーク OS である OcNOS を提供しています。1999 年以来のネットワーク技術の知見と世界 600+ のオペレーターでの実績により、Edgecore Networks、UfiSpace、Celestica などのパートナーによる検証済みオープンハードウェア上で、オープンかつマルチベンダーで、コスト効率が高く柔軟なネットワークインフラを実現します。IP Infusion はACCESS CO., LTD.（東京証券取引所: 4813）の完全子会社です。
メディア窓口
For press inquiries, analyst briefings, or media materials, please チームへお問い合わせ or email pr@ipinfusion.com.
将来見通しに関する記述
本リリースには、IP Infusion の製品、技術および計画に関する将来見通しの記述が含まれる場合があります。将来見通しに関する記述は公表日時点で入手可能な情報に基づいており、リスクと不確実性を伴います。実際の結果は異なる可能性があります。製品計画、機能、リリース時期および提供状況は予告なく変更されることがあり、確約、約束または法的義務を構成するものではありません。IP Infusion は将来見通しに関する記述を更新する義務を負いません。